Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Redhill Biopharma Ltd in the last 12 months.
There are not yet two fiscal years of reported share counts for Redhill Biopharma Ltd.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
YA
Yorkville Advisors Global, LP
|
122.1K | 0.00% | −228.7K (−65.2%) | Q4 '25 | 0.1% | |
|
Shares held by quarter
Peak holding386.6K (Q4'25)
Change over 8 quarters+122.1K
Share of the company0.000%
|
||||||
|
GS
Gagnon Securities LLC
|
88.4K | 0.00% | Unchanged | Q3 '25 | 0.0% | |
|
Shares held by quarter
Peak holding88.4K (Q1'26)
Change over 8 quarters+88.4K
Share of the company0.000%
|
||||||
16 more super investors behind a free account
See every manager holding Redhill Biopharma Ltd, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
FN
Fidelity Concord Street Trust
|
$349 | 41 | 0.00% | 0.00% | August 31, 2024 |
Loading...